Jack Stewart discusses SOR-C18 leading the phase 1b clinical trial in pancreatic cancer
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13 is the leading drug in a phase 1b clinical trial in late stage pancreatic cancer.
Author: Cancer-News
Added: 08/23/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts